Platinum Investment Management Ltd / 430
Platinum Investment Management Ltd’s Terns Pharmaceuticals Inc Position
Does Platinum Investment Management Ltd own Terns Pharmaceuticals Inc (430)? Yes — 110.7K shares worth $6M (+1.47% of its 13F portfolio) as of Q1 2026.
Position Value
$6M
Q1 2026
Shares
110.7K
% of Portfolio
+1.47%
Quarters Held
3
currently held
Position History 430
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Platinum Investment Management Ltd’s full portfolio or all institutional holders of 430.